Assay Development Scientist, IHC
NeoGenomics Laboratories
Summary
As an Assay Development Scientist you are responsible for conducting scientific experiments/processes leading to the successful completion of client projects and company projects including the development of high value, proprietary research or diagnostic Immunohistochemistry (IHC) products, new methods and technology development. You will provide accurate and pertinent scientific data according to agreed methods, procedures, and techniques within the established project schedules.
Job description
Responsibilities
- Leads project design and feasibility studies.
- Drives all aspects of the project management process from initiation, planning, execution, control and closure. Manages all projects proactively.
- Responsible for creating and maintaining project timelines for each project, and uses these timelines to track and manage a project's progress.
- Represents the department in a diverse range of settings, including with other departments, clients, audits, vendors, conferences.
- Performs the literature review, assists with technical design of new project/product developments
- Analyzes and presents data to management team.
- Provides support to research collaborations, clinical trials and other department projects.
- Prepares high quality technical reports (including validation, verification, final project) and documentation including posters/papers, client presentations and technical content for marketing materials.
Experience, Educations and Qualifications
- B.S or M.S. in a life, physical or computer science with related experience. Ph.D. in a life, physical or computer science preferred.
- Four or more years of related immunohistochemistry (IHC)
- Solid understanding of laboratory and/or analytical techniques.
- Ability to develop and deliver complex directions and scientific project plans.
- Detail orientated with ability to capture and record complex scientific data accurately and reliably.
- Excellent written and verbal presentation skills and the ability to use software tools to produce high impact presentations of data.
- Ability to problem solve independently and escalate problems appropriately in a timely manner.
- Ability to work independently and within a team environment.
- Must be able to work in a fast paced, multi-tasking environment and maintain production and quality standards.
- Must be able to work in a laboratory environment and comply with safety policies and standards outlined in the Safety Manual.
Requirements
- B.S or M.S. in a life, physical or computer science with related experience
- Ph.D. in a life, physical or computer science preferred
- Four or more years of related immunohistochemistry (IHC)
- Solid understanding of laboratory and/or analytical techniques
- Ability to develop and deliver complex directions and scientific project plans
- Detail orientated with ability to capture and record complex scientific data accurately and reliably
- Excellent written and verbal presentation skills and the ability to use software tools to produce high impact presentations of data
- Ability to problem solve independently and escalate problems appropriately in a timely manner
- Ability to work independently and within a team environment
- Must be able to work in a fast paced, multi-tasking environment and maintain production and quality standards
- Must be able to work in a laboratory environment and comply with safety policies and standards outlined in the Safety Manual
Benefits
- Health Insurance
- 401(k) Matching
- Employee Stock Purchase Program
- Tuition Reimbursement
- Leadership Development
- Paid Time Off
- Wellness Courses
- Employee Resource Groups
Company overview
NeoGenomics Laboratories, Inc. is a premier cancer diagnostics company specializing in comprehensive cancer genetics testing and oncology data solutions. Founded in 2002 and headquartered in Fort Myers, Florida, the company operates as a publicly traded entity on Nasdaq under the ticker NEO. NeoGenomics provides one of the most extensive oncology-focused testing menus worldwide, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing services. The company's testing portfolio includes cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics, with a particular emphasis on next-generation sequencing (NGS) technologies. With approximately 2,200 employees across 13 locations in the United States and Europe, NeoGenomics processes over 1.7 million cancer-related tests annually, including more than 100,000 NGS tests, serving about 4,400 medical sites and providing answers to more than 500,000 patients each year. The company maintains CAP-accredited and CLIA-certified laboratories throughout its network and has established a significant presence in cancer research through its Pharma Services Division, which supports pharmaceutical clients in clinical trials and drug development.